Your High-Enrolling Clinical Research Partner in India

India Clinical Research Partner

Designed for high-enrollment studies requiring speed, scale, and predictable execution. Backed by the SRM Group, a $1.4B+ leader in hospital systems and education.
Get in Touch

500,000+

Patients Annually

400+

Clinical Sites

800+

Clinicians

15+

Years Experience

Built for Speed, Scale, and Quality

InoRx integrates embedded investigators, clinical sites, and direct patient access within the SRM hospital ecosystem — resulting in faster enrollment, stronger retention, and more predictable execution.

Faster Study Start & Enrollment

Embedded hospital infrastructure enables rapid site activation and patient recruitment without external site dependency.

High-Enrollment Execution Model

Direct access to large pre-existing patient populations supports consistent enrollment across Phase I–IV programs.

Quality Without Tradeoffs

ICMR-certified environment with established clinical, safety, and regulatory processes. Audit-ready data aligned with global standards.

Proven in High-Volume Settings

15+ years of execution within the SRM hospital network, with global CRO collaboration including IQVIA.

Deep Expertise Across Key Therapeutic Areas

Supported by high-volume patient populations and integrated clinical environments within the SRM network.

Infectious Diseases & Vaccines

Rapid enrollment in acute care settings

Respiratory & Pulmonary

Asthma, COPD, and infectious respiratory studies

Inflammatory & Immune Conditions

Longitudinal cohorts and chronic disease access

Dermatology

Access to diverse patient populations

Biosimilars & Generics (SMD)

Bioequivalence and PK/PD execution

Cardiometabolic

Diabetes and cardiovascular outcomes

Oncology

Biosimilar programs with long-term follow-up

Women's & Neonatal Health

Peri/post-partum, neonatal, OB/GYN populations

Supporting Every Phase of Development

From first-in-human studies to large-scale post-marketing registries, InoRx delivers across the full clinical development spectrum.

First-in-Human

Phase 1a/1b, disease-agnostic studies. 20-bed unit operational today, expandable to 30–50 beds within 1–2 months.

Large-Scale & Real-World

Disease-focused and registrational programs with rapid recruitment across 400+ sites and 500,000+ annual patient touchpoints.

Fast, High-Volume 
Enrollment

PK/PD, bioequivalence, post-marketing surveillance, and real-world evidence with compliant long-term follow-up.

Clinical Infrastructure & Patient Access

InoRx operates an integrated site and hospital infrastructure enabling rapid capacity scaling without external site dependency.

Clinical & Laboratory Capabilities

  • Phase 1 unit with 20 beds operational; expandable to 30–50 beds in 1–2 months
  • Integrated hospital infrastructure — no external site dependency for scaling
  • Central lab supporting high-volume sample processing
  • Bioanalytical capabilities for PK/PD and bioequivalence studies
  • Standardized, validated sample handling, storage, and analysis

Patient Access & Site Network

  • 500,000+ patients accessible annually through the SRM network
  • 400+ clinical sites across SRM and affiliated network
  • 800+ clinicians including 200+ principal investigators
  • Strong patient retention via continuity of care within the hospital system
  • Global CRO collaboration including IQVIA

End-to-End Clinical Development Support

Full-service capabilities from trial design through regulatory submission and post-market surveillance.

Trial Design & Feasibility

Protocol optimization for high-enrollment settings

Clinical Operations & Monitoring

On-site and remote monitoring capabilities

Data Management & Analysis

Statistical support and audit-ready datasets

Regulatory Submission Support

ICMR and global regulatory processes

Safety & Pharmacovigilance

Structured safety reporting and monitoring

Biosimilar Development

Phase II–III registrational trial support

Generics (SMD) & Bioequivalence

High-volume BE study execution

Phase IV & Real-World Evidence

Post-marketing and registry programs

Partner with InoRx in India

Ready to accelerate your clinical program? Contact us to discuss feasibility, site capabilities, and how InoRx can meet your enrollment goals.
Download Fact Sheet

Webinar On Demand

How India Can Accelerate US Clinical Trials – Reducing Timelines Without Compromising Quality

Watch Now